Lyra Therapeutics Inc (LYRA)
0.2666
0.00 (0.00%)
USD |
NASDAQ |
Jun 24, 16:00
0.27
0.00 (0.00%)
After-Hours: 20:00
Lyra Therapeutics Shareholders Equity (Quarterly): 77.50M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 77.50M |
| December 31, 2023 | 89.42M |
| September 30, 2023 | 84.24M |
| June 30, 2023 | 98.58M |
| March 31, 2023 | 66.09M |
| December 31, 2022 | 80.75M |
| September 30, 2022 | 93.22M |
| June 30, 2022 | 111.03M |
| March 31, 2022 | 28.16M |
| Date | Value |
|---|---|
| December 31, 2021 | 34.32M |
| September 30, 2021 | 47.19M |
| June 30, 2021 | 57.50M |
| March 31, 2021 | 67.55M |
| December 31, 2020 | 74.49M |
| September 30, 2020 | 80.91M |
| June 30, 2020 | 86.82M |
| March 31, 2020 | -126.78M |
| December 31, 2019 | -123.34M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-126.78M
Minimum
Mar 2020
111.03M
Maximum
Jun 2022
51.54M
Average
76.00M
Median
Shareholders Equity (Quarterly) Benchmarks
| Integra Lifesciences Holdings Corp | 2.901B |
| Perspective Therapeutics Inc | 229.89M |
| Electromed Inc | 42.54M |
| Xtant Medical Holdings Inc | 47.68M |
| Asensus Surgical Inc | 13.02M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 141.53M |
| Total Liabilities (Quarterly) | 64.02M |
| Current Ratio | 4.777 |